Clinical Trial Update: Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cabergoline versus calcium infusion for prevention of ovarian hyperstimulation syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• calcium infusion (calcium infusion)

Snippet

Sponsor: Benha University | Conditions: Ovarian Hyperstimulation | Phase 3 | Status: COMPLETED